Vaccination strategies between compulsion and incentives. The Italian Green Pass experience
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:21 |
---|---|
Enthalten in: |
Expert review of vaccines - 21(2022), 4 vom: 28. Apr., Seite 423-425 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Stefanizzi, Pasquale [VerfasserIn] |
---|
Links: |
---|
Themen: |
COVID-19 |
---|
Anmerkungen: |
Date Completed 01.04.2022 Date Revised 01.04.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1080/14760584.2022.2023012 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM334980615 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM334980615 | ||
003 | DE-627 | ||
005 | 20231225224839.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/14760584.2022.2023012 |2 doi | |
028 | 5 | 2 | |a pubmed24n1116.xml |
035 | |a (DE-627)NLM334980615 | ||
035 | |a (NLM)34962214 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Stefanizzi, Pasquale |e verfasserin |4 aut | |
245 | 1 | 0 | |a Vaccination strategies between compulsion and incentives. The Italian Green Pass experience |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 01.04.2022 | ||
500 | |a Date Revised 01.04.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
650 | 4 | |a Editorial | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a immunization campaign | |
650 | 4 | |a public health | |
650 | 4 | |a vaccine hesitancy | |
700 | 1 | |a Bianchi, Francesco Paolo |e verfasserin |4 aut | |
700 | 1 | |a Brescia, Nazario |e verfasserin |4 aut | |
700 | 1 | |a Ferorelli, Davide |e verfasserin |4 aut | |
700 | 1 | |a Tafuri, Silvio |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Expert review of vaccines |d 2002 |g 21(2022), 4 vom: 28. Apr., Seite 423-425 |w (DE-627)NLM126545200 |x 1744-8395 |7 nnns |
773 | 1 | 8 | |g volume:21 |g year:2022 |g number:4 |g day:28 |g month:04 |g pages:423-425 |
856 | 4 | 0 | |u http://dx.doi.org/10.1080/14760584.2022.2023012 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 21 |j 2022 |e 4 |b 28 |c 04 |h 423-425 |